Detalles de la búsqueda
1.
Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells.
Biol Blood Marrow Transplant
; 18(1): 125-33, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21767515
2.
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.
Blood
; 114(5): 1099-109, 2009 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19423725
3.
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
JAMA
; 306(17): 1874-83, 2011 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22045765
4.
Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.
Biol Blood Marrow Transplant
; 16(8): 1145-54, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20197102
5.
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.
Blood
; 112(3): 903-9, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18519812
6.
E. Donnall Thomas (1920-2012).
Proc Natl Acad Sci U S A
; 109(51): 20777-8, 2012 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23197829
7.
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Biol Blood Marrow Transplant
; 14(11): 1279-87, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18940683
8.
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Biol Blood Marrow Transplant
; 14(2): 246-55, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18215785
9.
Protective conditioning for acute graft-versus-host disease.
N Engl J Med
; 353(13): 1321-31, 2005 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-16192477
10.
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
J Clin Oncol
; 23(16): 3819-29, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15809448
11.
Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience.
Exp Hematol
; 31(10): 981-6, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14550815
12.
A rare combination of two inherited disorders in one patient: pyruvate kinase deficiency and hemochromatosis.
Ann Hematol
; 88(8): 815-6, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19137298
13.
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
Int J Hematol
; 76 Suppl 1: 184-9, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12430851
14.
Patients beware: commercialized stem cell treatments on the web.
Cell Stem Cell
; 7(1): 43-9, 2010 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20621049
15.
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
J Clin Oncol
; 26(30): 4912-20, 2008 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18794548
16.
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood
; 110(7): 2744-8, 2007 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17595333
17.
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
Biol Blood Marrow Transplant
; 12(7): 703-11, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16785059
18.
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.
Biol Blood Marrow Transplant
; 12(4): 438-53, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16545728
19.
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Biol Blood Marrow Transplant
; 12(4): 454-65, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16545729
20.
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 11(1): 47-55, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15625544